We are live on ! Find out more
NDRAW

ENDRA Life Sciences Inc. Warrants

Delisted

NDRAW was delisted on the 12th of May, 2022.

3 hedge funds and large institutions have $2K invested in ENDRA Life Sciences Inc. Warrants in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding

Funds holding: 23 (+1)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.07%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$3.48K

Top Sellers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
-$18
Name Holding Trade Value Shares
Change
Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$2K +$3.48K +10,389 New
UBS Group
2
UBS Group
Switzerland
-$18 -55 -31%

NDRAW Hedge Fund Activity: Q1 2020 in Review

3 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences Inc. Warrants (NDRAW) for Q1 2020, worth a combined $2K.

Buyers outnumbered sellers: 1 fund opened new NDRAW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $3.48K. The largest seller was UBS Group, cutting an estimated $18.

  • 3 institutional investors held ENDRA Life Sciences Inc. Warrants (NDRAW) as of Q1 2020, up from 2 in Q4 2019.
  • Funds reported $2K of ENDRA Life Sciences Inc. Warrants stock for Q1 2020.
  • 1 fund opened new ENDRA Life Sciences Inc. Warrants positions in Q1 2020 and 0 closed out, a net change of +1 holder.
  • The largest ENDRA Life Sciences Inc. Warrants buyer in Q1 2020 was Susquehanna International Group, an estimated $3.48K added.
  • The largest ENDRA Life Sciences Inc. Warrants seller in Q1 2020 was UBS Group, an estimated $18 sold.

Based on aggregated 13F filings for Q1 2020.